Potential Tuberculostatic Agents: Micelle-Forming Copolymer Poly(ethylene glycol)-Poly(aspartic acid) Prodrug with Isoniazid

With the objective of obtaining slow‐acting isoniazid derivatives, of potential use as chemoprophylactics or chemotherapeutics in tuberculosis, the micelle‐forming copolymer of poly(ethylene glycol)‐ poly(aspartic acid) prodrug with isoniazid was synthesized. The derivative obtained was found to be...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archiv der Pharmazie (Weinheim) 2001-06, Vol.334 (6), p.189-193
Hauptverfasser: Silva, M., Lara, A. S., Leite, C. Q. F., Ferreira, E. I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 193
container_issue 6
container_start_page 189
container_title Archiv der Pharmazie (Weinheim)
container_volume 334
creator Silva, M.
Lara, A. S.
Leite, C. Q. F.
Ferreira, E. I.
description With the objective of obtaining slow‐acting isoniazid derivatives, of potential use as chemoprophylactics or chemotherapeutics in tuberculosis, the micelle‐forming copolymer of poly(ethylene glycol)‐ poly(aspartic acid) prodrug with isoniazid was synthesized. The derivative obtained was found to be active in Mycobacterium tuberculosis culture, with a minimal inhibitory concentration (MIC) 5.6 times lower than that of the tuberculostatic drug.
doi_str_mv 10.1002/1521-4184(200106)334:6<189::AID-ARDP189>3.0.CO;2-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71047640</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71047640</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5039-cc0779279fe4548096ee883c2c96d7d11c1370c7b69a4c1681b5f9d232474f353</originalsourceid><addsrcrecordid>eNqVkV1v0zAUhiMEYt3gL6BcILRepPjbSUFIVcdKpUGrMhh3R67jdB5u3NmJRhE_npSWwQU3XFm2Xz_n-DxJMsRogBEiLzEnOGM4Z6cEIYxEn1I2FK9xXgyHo-lZNlqczbvNGzpAg_HsFcnEg6R3_-hh0kNU8EwQSo-S4xhvEEIUEf44OcKYSV6gvJf8mPvG1I1VLr1slybo1vnYqMbqdLTqLuIwfW-1cc5k5z6sbb1Kx37j3XZtQjrv1lPTXG-dqU26clvtXT_7dariRoUdRWlb9tN58GVoV-mdba7TafS1Vd9t-SR5VCkXzdPDepJ8On97OX6XXcwm0_HoItMc0SLTGklZEFlUhnGWo0IYk-dUE12IUpYYa0wl0nIpCsU0Fjle8qooCSVMsopyepK82HM3wd-2JjawtnH3KVUb30aQGDEpGOqCi31QBx9jMBVsgl2rsAWMYOcEduOF3Xhh7wQ6JyCg0wDQOYGDE6CAYDwDAqKDPjtUb5drU_5BHiR0geeHgIpauSqoWtv4V2nGeFF0sc_72J11Zvs_nf27sd9HHTjbg21szLd7sApfQUgqOVx9mMDHL4srPpE5LOhPV5rB6Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71047640</pqid></control><display><type>article</type><title>Potential Tuberculostatic Agents: Micelle-Forming Copolymer Poly(ethylene glycol)-Poly(aspartic acid) Prodrug with Isoniazid</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Silva, M. ; Lara, A. S. ; Leite, C. Q. F. ; Ferreira, E. I.</creator><creatorcontrib>Silva, M. ; Lara, A. S. ; Leite, C. Q. F. ; Ferreira, E. I.</creatorcontrib><description>With the objective of obtaining slow‐acting isoniazid derivatives, of potential use as chemoprophylactics or chemotherapeutics in tuberculosis, the micelle‐forming copolymer of poly(ethylene glycol)‐ poly(aspartic acid) prodrug with isoniazid was synthesized. The derivative obtained was found to be active in Mycobacterium tuberculosis culture, with a minimal inhibitory concentration (MIC) 5.6 times lower than that of the tuberculostatic drug.</description><identifier>ISSN: 0365-6233</identifier><identifier>EISSN: 1521-4184</identifier><identifier>DOI: 10.1002/1521-4184(200106)334:6&lt;189::AID-ARDP189&gt;3.0.CO;2-6</identifier><identifier>PMID: 11475908</identifier><identifier>CODEN: ARPMAS</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag GmbH</publisher><subject>Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antitubercular Agents - chemical synthesis ; Antitubercular Agents - pharmacology ; Biological and medical sciences ; co-polymer poly(ethylene glycol)-poly(aspartic acid) ; Excipients ; isoniazid ; Isoniazid - chemistry ; Isoniazid - pharmacology ; Medical sciences ; micelle-forming polymer ; Micelles ; Microbial Sensitivity Tests ; Mycobacterium tuberculosis - drug effects ; Peptides ; Pharmacology. Drug treatments ; Polyethylene Glycols ; potential tuberculostatic agent ; prodrug ; Prodrugs - chemical synthesis ; Prodrugs - pharmacology</subject><ispartof>Archiv der Pharmazie (Weinheim), 2001-06, Vol.334 (6), p.189-193</ispartof><rights>2001 WILEY‐VCH Verlag GmbH, Weinheim, Fed. Rep. of Germany</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F1521-4184%28200106%29334%3A6%3C189%3A%3AAID-ARDP189%3E3.0.CO%3B2-6$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F1521-4184%28200106%29334%3A6%3C189%3A%3AAID-ARDP189%3E3.0.CO%3B2-6$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1044599$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11475908$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Silva, M.</creatorcontrib><creatorcontrib>Lara, A. S.</creatorcontrib><creatorcontrib>Leite, C. Q. F.</creatorcontrib><creatorcontrib>Ferreira, E. I.</creatorcontrib><title>Potential Tuberculostatic Agents: Micelle-Forming Copolymer Poly(ethylene glycol)-Poly(aspartic acid) Prodrug with Isoniazid</title><title>Archiv der Pharmazie (Weinheim)</title><addtitle>Arch. Pharm. Pharm. Med. Chem</addtitle><description>With the objective of obtaining slow‐acting isoniazid derivatives, of potential use as chemoprophylactics or chemotherapeutics in tuberculosis, the micelle‐forming copolymer of poly(ethylene glycol)‐ poly(aspartic acid) prodrug with isoniazid was synthesized. The derivative obtained was found to be active in Mycobacterium tuberculosis culture, with a minimal inhibitory concentration (MIC) 5.6 times lower than that of the tuberculostatic drug.</description><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antitubercular Agents - chemical synthesis</subject><subject>Antitubercular Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>co-polymer poly(ethylene glycol)-poly(aspartic acid)</subject><subject>Excipients</subject><subject>isoniazid</subject><subject>Isoniazid - chemistry</subject><subject>Isoniazid - pharmacology</subject><subject>Medical sciences</subject><subject>micelle-forming polymer</subject><subject>Micelles</subject><subject>Microbial Sensitivity Tests</subject><subject>Mycobacterium tuberculosis - drug effects</subject><subject>Peptides</subject><subject>Pharmacology. Drug treatments</subject><subject>Polyethylene Glycols</subject><subject>potential tuberculostatic agent</subject><subject>prodrug</subject><subject>Prodrugs - chemical synthesis</subject><subject>Prodrugs - pharmacology</subject><issn>0365-6233</issn><issn>1521-4184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkV1v0zAUhiMEYt3gL6BcILRepPjbSUFIVcdKpUGrMhh3R67jdB5u3NmJRhE_npSWwQU3XFm2Xz_n-DxJMsRogBEiLzEnOGM4Z6cEIYxEn1I2FK9xXgyHo-lZNlqczbvNGzpAg_HsFcnEg6R3_-hh0kNU8EwQSo-S4xhvEEIUEf44OcKYSV6gvJf8mPvG1I1VLr1slybo1vnYqMbqdLTqLuIwfW-1cc5k5z6sbb1Kx37j3XZtQjrv1lPTXG-dqU26clvtXT_7dariRoUdRWlb9tN58GVoV-mdba7TafS1Vd9t-SR5VCkXzdPDepJ8On97OX6XXcwm0_HoItMc0SLTGklZEFlUhnGWo0IYk-dUE12IUpYYa0wl0nIpCsU0Fjle8qooCSVMsopyepK82HM3wd-2JjawtnH3KVUb30aQGDEpGOqCi31QBx9jMBVsgl2rsAWMYOcEduOF3Xhh7wQ6JyCg0wDQOYGDE6CAYDwDAqKDPjtUb5drU_5BHiR0geeHgIpauSqoWtv4V2nGeFF0sc_72J11Zvs_nf27sd9HHTjbg21szLd7sApfQUgqOVx9mMDHL4srPpE5LOhPV5rB6Q</recordid><startdate>200106</startdate><enddate>200106</enddate><creator>Silva, M.</creator><creator>Lara, A. S.</creator><creator>Leite, C. Q. F.</creator><creator>Ferreira, E. I.</creator><general>WILEY-VCH Verlag GmbH</general><general>WILEY‐VCH Verlag GmbH</general><general>Wiley-VCH</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200106</creationdate><title>Potential Tuberculostatic Agents: Micelle-Forming Copolymer Poly(ethylene glycol)-Poly(aspartic acid) Prodrug with Isoniazid</title><author>Silva, M. ; Lara, A. S. ; Leite, C. Q. F. ; Ferreira, E. I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5039-cc0779279fe4548096ee883c2c96d7d11c1370c7b69a4c1681b5f9d232474f353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antitubercular Agents - chemical synthesis</topic><topic>Antitubercular Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>co-polymer poly(ethylene glycol)-poly(aspartic acid)</topic><topic>Excipients</topic><topic>isoniazid</topic><topic>Isoniazid - chemistry</topic><topic>Isoniazid - pharmacology</topic><topic>Medical sciences</topic><topic>micelle-forming polymer</topic><topic>Micelles</topic><topic>Microbial Sensitivity Tests</topic><topic>Mycobacterium tuberculosis - drug effects</topic><topic>Peptides</topic><topic>Pharmacology. Drug treatments</topic><topic>Polyethylene Glycols</topic><topic>potential tuberculostatic agent</topic><topic>prodrug</topic><topic>Prodrugs - chemical synthesis</topic><topic>Prodrugs - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Silva, M.</creatorcontrib><creatorcontrib>Lara, A. S.</creatorcontrib><creatorcontrib>Leite, C. Q. F.</creatorcontrib><creatorcontrib>Ferreira, E. I.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Archiv der Pharmazie (Weinheim)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Silva, M.</au><au>Lara, A. S.</au><au>Leite, C. Q. F.</au><au>Ferreira, E. I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Potential Tuberculostatic Agents: Micelle-Forming Copolymer Poly(ethylene glycol)-Poly(aspartic acid) Prodrug with Isoniazid</atitle><jtitle>Archiv der Pharmazie (Weinheim)</jtitle><addtitle>Arch. Pharm. Pharm. Med. Chem</addtitle><date>2001-06</date><risdate>2001</risdate><volume>334</volume><issue>6</issue><spage>189</spage><epage>193</epage><pages>189-193</pages><issn>0365-6233</issn><eissn>1521-4184</eissn><coden>ARPMAS</coden><abstract>With the objective of obtaining slow‐acting isoniazid derivatives, of potential use as chemoprophylactics or chemotherapeutics in tuberculosis, the micelle‐forming copolymer of poly(ethylene glycol)‐ poly(aspartic acid) prodrug with isoniazid was synthesized. The derivative obtained was found to be active in Mycobacterium tuberculosis culture, with a minimal inhibitory concentration (MIC) 5.6 times lower than that of the tuberculostatic drug.</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag GmbH</pub><pmid>11475908</pmid><doi>10.1002/1521-4184(200106)334:6&lt;189::AID-ARDP189&gt;3.0.CO;2-6</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0365-6233
ispartof Archiv der Pharmazie (Weinheim), 2001-06, Vol.334 (6), p.189-193
issn 0365-6233
1521-4184
language eng
recordid cdi_proquest_miscellaneous_71047640
source MEDLINE; Wiley Online Library All Journals
subjects Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antitubercular Agents - chemical synthesis
Antitubercular Agents - pharmacology
Biological and medical sciences
co-polymer poly(ethylene glycol)-poly(aspartic acid)
Excipients
isoniazid
Isoniazid - chemistry
Isoniazid - pharmacology
Medical sciences
micelle-forming polymer
Micelles
Microbial Sensitivity Tests
Mycobacterium tuberculosis - drug effects
Peptides
Pharmacology. Drug treatments
Polyethylene Glycols
potential tuberculostatic agent
prodrug
Prodrugs - chemical synthesis
Prodrugs - pharmacology
title Potential Tuberculostatic Agents: Micelle-Forming Copolymer Poly(ethylene glycol)-Poly(aspartic acid) Prodrug with Isoniazid
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T17%3A44%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Potential%20Tuberculostatic%20Agents:%20Micelle-Forming%20Copolymer%20Poly(ethylene%20glycol)-Poly(aspartic%20acid)%20Prodrug%20with%20Isoniazid&rft.jtitle=Archiv%20der%20Pharmazie%20(Weinheim)&rft.au=Silva,%20M.&rft.date=2001-06&rft.volume=334&rft.issue=6&rft.spage=189&rft.epage=193&rft.pages=189-193&rft.issn=0365-6233&rft.eissn=1521-4184&rft.coden=ARPMAS&rft_id=info:doi/10.1002/1521-4184(200106)334:6%3C189::AID-ARDP189%3E3.0.CO;2-6&rft_dat=%3Cproquest_cross%3E71047640%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71047640&rft_id=info:pmid/11475908&rfr_iscdi=true